insights_auto
Why is CSBR down 4,21%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
4,40 $
arrow_downward
-4,21%(-0,19) 1D
19 նոյ, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,47 $
High
4,47 $
Low
4,40 $
Mkt. cap
61,24 մլն
Avg. vol.
6,90 հզր
Volume
4,87 հզր
52-wk high
8,31 $
52-wk low
4,40 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
13,92 մլն
No. of employees
217
Open
4,47 $
High
4,47 $
Low
4,40 $
Mkt. cap
61,24 մլն
Avg. vol.
6,90 հզր
Volume
4,87 հզր
52-wk high
8,31 $
52-wk low
4,40 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
13,92 մլն
No. of employees
217
News stories
From web sources and news partners
FXStreet
·
43 րոպե առաջ
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Traders Union
·
39 րոպե առաջ
Gunjan Banerji: Only 38 S&P 500 stocks rose, fewest gainers since December 31, 2025
The Motley Fool
·
24 րոպե առաջ
Stock Market Today, Nov. 19: Dow Plunges 1,100 Points as the S&P 500 Suffers Its 6th Straight Day of Losses
Investing.com
·
35 րոպե առաջ
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 2.19%
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersՀաքենսաք, Նյու Ջերսի, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websitechampionsoncology.com